• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Hematoma (1884)
Event Date 08/24/2017
Event Type  Death  
Manufacturer Narrative
Brasiliense lbc, aguilar-salinas p, miller da, tawk rg, sauvageau ea, hanel ra, analysis of predictors and probability of aneurysm occlusion in the ica after treatment with pipeline embolization device, world neurosurgery (2017), doi: 10.1016/j.Wneu.2017.08.099.The pipeline device will not be returned for evaluation as it was implanted in the patient.Based on the reported information, there does not appear to have been any defect of the device during use.The event occurred in the patient post-procedure and its cause could not be conclusively determined from the provided information.Mdrs related to this article: 2029214-2017-01193 2029214-2017-01194.
 
Event Description
Medtronic literature review found reports of a patient death after pipeline implantation.The purpose of this study was to investigate predictors and rate of occlusion for aneurysms along the internal carotid artery (ica).The authors analyzed the results of 83 patients with 117 aneurysms who underwent treatment with the pipeline embolization device (ped); a total of 106 peds were deployed.The patients¿ mean age was 61.2 years; 75 of the patients were female.The article notes that three patients died sometime after ped implantation.Of the three deaths, only one death may have been related to the ped: the patient ((b)(6), male) died approximately 50 days after treatment following recurrent subdural hematomas likely secondary to the antiplatelet regimen.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE EMBOLIZATION DEVICE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key6986255
MDR Text Key90508206
Report Number2029214-2017-01194
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100018.S004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 10/29/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/30/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/03/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age79 YR
-
-